世界のミルタザピン市場予測（～2028年）：15Mg錠、30Mg錠、45Mg錠

• 英文タイトル：Global Mirtazapine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8896 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ミルタザピン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のミルタザピンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ミルタザピン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・15Mg錠、30Mg錠、45Mg錠 用途別セグメントは次のように区分されます。 ・うつ病、不眠症、減量、気分変動、その他 世界のミルタザピン市場の主要な市場プレーヤーは以下のとおりです。 ・Novartis、Organon、CIMA Labs.Inc.、Merck & Co、Teva、Mylan、Sun Pharmaceutical、IMPAX、Aurobindo Pharma、Zydus Pharmaceuticals、APOTEX、Harbin Sanlian Pharmaceutical、Shanxi Kangbao Biological Products、Huayu Pharmaceutical、Hangzhou Moshadong Pharmaceutical、Shanghai Xinyi Vientiane Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ミルタザピン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なミルタザピンメーカーの企業概要、2019年～2022年までのミルタザピンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なミルタザピンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ミルタザピンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのミルタザピンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのミルタザピン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびミルタザピンの産業チェーンを掲載しています。 ・第13、14、15章では、ミルタザピンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Organon、CIMA Labs.Inc.、Merck & Co、Teva、Mylan、Sun Pharmaceutical、IMPAX、Aurobindo Pharma、Zydus Pharmaceuticals、APOTEX、Harbin Sanlian Pharmaceutical、Shanxi Kangbao Biological Products、Huayu Pharmaceutical、Hangzhou Moshadong Pharmaceutical、Shanghai Xinyi Vientiane Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：15Mg錠、30Mg錠、45Mg錠 ・用途別分析2017年-2028年：うつ病、不眠症、減量、気分変動、その他 ・ミルタザピンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ミルタザピンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ミルタザピンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ミルタザピンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ミルタザピンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Mirtazapine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mirtazapine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Depression accounting for % of the Mirtazapine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 15 Mg Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mirtazapine include Novartis, Organon, CIMA Labs.Inc., Merck & Co, and Teva, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mirtazapine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
15 Mg Tablets
30 Mg Tablets
45 Mg Tablets
Market segment by Application can be divided into
Depression
Insomnia
Weight Loss
Mood Swings
Other
The key market players for global Mirtazapine market are listed below:
Novartis
Organon
CIMA Labs.Inc.
Merck & Co
Teva
Mylan
Sun Pharmaceutical
IMPAX
Aurobindo Pharma
Zydus Pharmaceuticals
APOTEX
Harbin Sanlian Pharmaceutical
Shanxi Kangbao Biological Products
Huayu Pharmaceutical
Hangzhou Moshadong Pharmaceutical
Shanghai Xinyi Vientiane Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mirtazapine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mirtazapine, with price, sales, revenue and global market share of Mirtazapine from 2019 to 2022.
Chapter 3, the Mirtazapine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mirtazapine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mirtazapine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mirtazapine.
Chapter 13, 14, and 15, to describe Mirtazapine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Mirtazapine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mirtazapine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 15 Mg Tablets
1.2.3 30 Mg Tablets
1.2.4 45 Mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Mirtazapine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Depression
1.3.3 Insomnia
1.3.4 Weight Loss
1.3.5 Mood Swings
1.3.6 Other
1.4 Global Mirtazapine Market Size & Forecast
1.4.1 Global Mirtazapine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mirtazapine Sales in Volume (2017-2028)
1.4.3 Global Mirtazapine Price (2017-2028)
1.5 Global Mirtazapine Production Capacity Analysis
1.5.1 Global Mirtazapine Total Production Capacity (2017-2028)
1.5.2 Global Mirtazapine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mirtazapine Market Drivers
1.6.2 Mirtazapine Market Restraints
1.6.3 Mirtazapine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Mirtazapine Product and Services
2.1.4 Novartis Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Organon
2.2.1 Organon Details
2.2.2 Organon Major Business
2.2.3 Organon Mirtazapine Product and Services
2.2.4 Organon Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CIMA Labs.Inc.
2.3.1 CIMA Labs.Inc. Details
2.3.2 CIMA Labs.Inc. Major Business
2.3.3 CIMA Labs.Inc. Mirtazapine Product and Services
2.3.4 CIMA Labs.Inc. Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co Mirtazapine Product and Services
2.4.4 Merck & Co Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Mirtazapine Product and Services
2.5.4 Teva Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Mirtazapine Product and Services
2.6.4 Mylan Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Mirtazapine Product and Services
2.7.4 Sun Pharmaceutical Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IMPAX
2.8.1 IMPAX Details
2.8.2 IMPAX Major Business
2.8.3 IMPAX Mirtazapine Product and Services
2.8.4 IMPAX Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Mirtazapine Product and Services
2.9.4 Aurobindo Pharma Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Zydus Pharmaceuticals
2.10.1 Zydus Pharmaceuticals Details
2.10.2 Zydus Pharmaceuticals Major Business
2.10.3 Zydus Pharmaceuticals Mirtazapine Product and Services
2.10.4 Zydus Pharmaceuticals Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 APOTEX
2.11.1 APOTEX Details
2.11.2 APOTEX Major Business
2.11.3 APOTEX Mirtazapine Product and Services
2.11.4 APOTEX Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Harbin Sanlian Pharmaceutical
2.12.1 Harbin Sanlian Pharmaceutical Details
2.12.2 Harbin Sanlian Pharmaceutical Major Business
2.12.3 Harbin Sanlian Pharmaceutical Mirtazapine Product and Services
2.12.4 Harbin Sanlian Pharmaceutical Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanxi Kangbao Biological Products
2.13.1 Shanxi Kangbao Biological Products Details
2.13.2 Shanxi Kangbao Biological Products Major Business
2.13.3 Shanxi Kangbao Biological Products Mirtazapine Product and Services
2.13.4 Shanxi Kangbao Biological Products Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Huayu Pharmaceutical
2.14.1 Huayu Pharmaceutical Details
2.14.2 Huayu Pharmaceutical Major Business
2.14.3 Huayu Pharmaceutical Mirtazapine Product and Services
2.14.4 Huayu Pharmaceutical Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Hangzhou Moshadong Pharmaceutical
2.15.1 Hangzhou Moshadong Pharmaceutical Details
2.15.2 Hangzhou Moshadong Pharmaceutical Major Business
2.15.3 Hangzhou Moshadong Pharmaceutical Mirtazapine Product and Services
2.15.4 Hangzhou Moshadong Pharmaceutical Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Shanghai Xinyi Vientiane Pharmaceutical
2.16.1 Shanghai Xinyi Vientiane Pharmaceutical Details
2.16.2 Shanghai Xinyi Vientiane Pharmaceutical Major Business
2.16.3 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Product and Services
2.16.4 Shanghai Xinyi Vientiane Pharmaceutical Mirtazapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mirtazapine Breakdown Data by Manufacturer
3.1 Global Mirtazapine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mirtazapine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mirtazapine
3.4 Market Concentration Rate
3.4.1 Top 3 Mirtazapine Manufacturer Market Share in 2021
3.4.2 Top 6 Mirtazapine Manufacturer Market Share in 2021
3.5 Global Mirtazapine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mirtazapine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mirtazapine Market Size by Region
4.1.1 Global Mirtazapine Sales in Volume by Region (2017-2028)
4.1.2 Global Mirtazapine Revenue by Region (2017-2028)
4.2 North America Mirtazapine Revenue (2017-2028)
4.3 Europe Mirtazapine Revenue (2017-2028)
4.4 Asia-Pacific Mirtazapine Revenue (2017-2028)
4.5 South America Mirtazapine Revenue (2017-2028)
4.6 Middle East and Africa Mirtazapine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mirtazapine Sales in Volume by Type (2017-2028)
5.2 Global Mirtazapine Revenue by Type (2017-2028)
5.3 Global Mirtazapine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mirtazapine Sales in Volume by Application (2017-2028)
6.2 Global Mirtazapine Revenue by Application (2017-2028)
6.3 Global Mirtazapine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mirtazapine Sales by Type (2017-2028)
7.2 North America Mirtazapine Sales by Application (2017-2028)
7.3 North America Mirtazapine Market Size by Country
7.3.1 North America Mirtazapine Sales in Volume by Country (2017-2028)
7.3.2 North America Mirtazapine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mirtazapine Sales by Type (2017-2028)
8.2 Europe Mirtazapine Sales by Application (2017-2028)
8.3 Europe Mirtazapine Market Size by Country
8.3.1 Europe Mirtazapine Sales in Volume by Country (2017-2028)
8.3.2 Europe Mirtazapine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mirtazapine Sales by Type (2017-2028)
9.2 Asia-Pacific Mirtazapine Sales by Application (2017-2028)
9.3 Asia-Pacific Mirtazapine Market Size by Region
9.3.1 Asia-Pacific Mirtazapine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mirtazapine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mirtazapine Sales by Type (2017-2028)
10.2 South America Mirtazapine Sales by Application (2017-2028)
10.3 South America Mirtazapine Market Size by Country
10.3.1 South America Mirtazapine Sales in Volume by Country (2017-2028)
10.3.2 South America Mirtazapine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mirtazapine Sales by Type (2017-2028)
11.2 Middle East & Africa Mirtazapine Sales by Application (2017-2028)
11.3 Middle East & Africa Mirtazapine Market Size by Country
11.3.1 Middle East & Africa Mirtazapine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mirtazapine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mirtazapine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mirtazapine
12.3 Mirtazapine Production Process
12.4 Mirtazapine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mirtazapine Typical Distributors
13.3 Mirtazapine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---